Upcoming Discipline Hearings

Hearing Dates: January 20, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that, as shareholder and director of the corporation that owned Health and Wellness Pharmacy in Windsor, Ontario, and as Designated Manager of Health and Wellness Pharmacy, Mr. Abdul committed professional misconduct in that

a) on various occasions between June 6, 2012 and October 25, 2013 he returned to stock and/or again sold or dispensed drugs previously sold or dispensed and delivered, namely Risperdal Consta, in various strengths;

b) between June 6, 2012 and October 25, 2013, he submitted false claims to ODB regarding units of Risperdal Consta, in various strengths, that were either not dispensed to patients, or were already the subject of previous claims that had been paid by ODB;

c) between June 6, 2012 and October 25, 2013, he created false records of dispensing and/or billing transactions in relation to the false claims submitted to ODB;

d) in or about May 2014, he provided the College’s investigator with prescription breakdown reports that did not reflect the true number of prescriptions of Risperdal Consta claimed by the Pharmacy from ODB;

e) In the alternative to d, he did not maintain adequate records of prescriptions of Risperdal Consta claimed by the Pharmacy from ODB between June 6, 2012 and October 25, 2013.

In particular, it is alleged that he

– returned to stock and/or again sold or dispensed drugs previously sold or dispensed and delivered, namely Risperdal Consta, in various strengths;

– falsified records relating to his practice;

– issued, in his professional capacity, a document that he knew contained a false or misleading statement;

– failed to keep records as required respecting his patients;

– submitted an account or charge for services that he knew was false or misleading;

– engaged in conduct relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonable be regarded by members as disgraceful, dishonourable and/or unprofessional.

Please note that the hearing on January 20, 2020, will commence at 11:00AM at the Ontario College of Pharmacists.

Hearing Dates: January 22, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, as a dispensing pharmacist and/or Designated Manager at Cundles Pharmacy in Barrie Ontario (the Pharmacy), and/or as a director and/or shareholder of the corporation that owned the Pharmacy, committed professional misconduct with respect to:

• False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totalling approximately $71,000 for 11 identified drug and other health products, from in or around March of 2015 to in or around February of 2017;
• Improper claims for prescriptions submitted to the ODB from the Pharmacy totalling approximately $62,000, for the period beginning in or around March of 2015 to in or around February of 2017, in relation to:
  1. Claims for patients who were deceased, for 26 identified prescriptions;
  2. Claims for allergy products for which the required forms were not obtained or retained, for 2 identified prescriptions;
  3. Claims for products in package sizes not listed in the ODB Formulary, for 3 identified prescriptions;
  4. Claims for extemporaneous mixtures where the amount charged exceeded the amount allowed, for 23 identified prescriptions;
  5. Claims for MedsCheck reviews which did not meet the criteria for reimbursement, in relation to 120 identified reviews;
  6. Claims for “no substitution” products for patients for whom the required forms were not obtained, for 372 identified prescriptions;
  7. Claims for Limited Use Products that did not meet the ODB’s criteria for reimbursement, for 44 identified prescriptions; and/or
  8. Claims for products different from those dispensed, including gabapentin, Ensure Plus and Cymbalta, for identified quantities and amounts.

In particular, it is alleged that he

• Failed to maintain a standard of the profession
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15 of the Ontario Drug Benefit Act
• Permitted, consented to, or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
• Failed to keep records as required respecting his patients
• Submitted an account or charge for services that he knew was false or misleading
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document he knew contained a false or misleading statement
• Engaged in conduct or preformed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: January 23, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ghobrial, as pharmacist and/or Designated Manager at Ancaster Village Pharmacy in Ancaster, Ontario, committed professional misconduct in that he

• Submitted claims to [Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about February 2017-February 2018

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Charged a fee that was excessive in relation to the service provided
• Charged a fee or amount that was excessive in relation to the service or product provided
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: January 30, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Awad, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at John Garland Pharmacy (the “Pharmacy”) in Etobicoke, Ontario, committed professional misconduct in that she

• Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
• Falsified a record relating to her practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
• Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017; and/or
• Submitted an account or charge for services that she knew or ought to have known was false and misleading with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting her patients and/or practice
• Falsified a record relating to her practice and/or a person’s health record
• Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement
• Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40(1) and 54(1) of Ontario Regulation 58/11
• Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
  1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40 and 54(1) of Ontario Regulation 58/11
  2. sections 5, 6, and 15(1) of the Ontario Drug Benefit Act and section 27 of Ontario Regulation 201/96
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: January 31, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Groodoyal, while employed as a pharmacy technician at the Transplant Outpatient Pharmacy at Toronto General Hospital in Toronto, Ontario (the “Pharmacy”), committed professional misconduct in that:

• Between January 2014 and April 2015, she dispensed a drug other than under the supervision or direction of a pharmacist, on one or more occasions.

In particular, it is alleged that she

• Contravened a term, condition or limitation imposed on her certificate of registration;
• Failed to maintain the standards of the profession;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, as follows:
  • s. 18 of Ontario Regulation 202/94 under the Pharmacy Act, 1991
• Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: February 3, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hadi committed professional misconduct in that

• On or about September 24, 2016, he committed sexual assault on a minor;
• On or about September 24, 2016, he did, without lawful authority, confine a minor;
• He failed to report to the College that on or about September 26, 2016 he charged with sexual assault and unlawful confinement, under sections 271 and 279(2) of the Criminal Code;
• On or about March 9, 2017, in written and/or electronic material he submitted to the College during the renewals of his certificate of registration he indicated that he was not the subject of a criminal proceeding, at a time he was charged with sexual assault and unlawful confinement, contrary to sections 271 and 279(2) of the Criminal Code;
• On or around March 8, 2018, in written and/or electronic material he submitted to the College during the renewals of his certificate of registration he indicated that he was not the subject of a criminal proceeding, at a time he was charged with sexual assault;
• On or about March 16, 2018, he was found guilty of sexual assault and unlawful confinement, contrary to sections 271 and 279(2) of the Criminal Code;
• He failed to report to the College that on or about March 16, 2018 he was convicted of sexual assault and unlawful confinement, under sections 271 and 279(2) of the Criminal Code; and
• He failed to report to the College that on or about October 16, 2018 he was found to have engaged in unprofessional conduct by a hearing tribunal of the Alberta College of Pharmacy.

In particular, it is alleged that he

• Was found guilty of offences that are relevant to his suitability to practice
• Contravened a term, condition or limitation imposed on his certificate of registration, as set out in section 5, paragraph 1 (ii) of Ontario Regulation 202/94
• Breached section 85.6.1 of the Health Professions Procedural Code
• Breached section 85.6.3 of the Health Professions Procedural Code
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: February 5, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Essa, while engaged in the practice of pharmacy as dispensing pharmacist and/or Designated Manager, committed professional misconduct in that

• In or about the period from May 15, 2015 to November 16, 2016, he failed to conduct proper narcotic reconciliations, and keep records of same, as required by the College’s Medication Procurement and Inventory Management Policy.
• In or about the period from January 1, 2013 to December 31, 2014 he failed to supply the required information to the Narcotics Monitoring System as required by s. 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22, and the Notice issued thereunder, with respect to one or more of the following products:
  i. Apo‐Diazepam 10mg
  ii. Apo‐Diazepam 5mg
  iii. Apo‐Lorazepam 1mg
  iv. Apo‐Oxazepam 30mg
  v. Ativan 1mg
  vi. Codeine Contin 100mg
  vii. Codeine Contin 50mg
  viii. Concerta 18mg
  ix. Concerta 27mg
  x. Concerta 36mg
  xi. Concerta 54mg
  xii. Demerol 50mg
  xiii. Endocet
  xiv. Hydromorph Contin 12mg
  xv. Hydromorph Contin 18mg
  xvi. Hydromorph Contin 6mg
  xvii. Oxyneo 10mg
  xviii. Oxyneo 15mg
  xix. Oxyneo 20mg
  xx. Oxyneo 40mg
  xxi. Pms‐Clonazepam R 0.5mg
  xxii. Ratio‐Oxycocet
  xxiii. Sandoz‐Fentanyl 25ug/hr
  xxiv. Sandoz‐Morphine SR 30mg
  xxv. Sandoz‐Morphine SR 60mg
  xxvi. Statex 10mg
  xxvii. Statex 5mg
  xxviii. Tylenol #3
• In or about the period from January 1, 1996 to December 31, 2016, he inappropriately provided pharmaceutical treatment to family members, contrary to the College’s Policy on Treating Self and Family Members.
• In or about the period from July 1, 2015 to November 6, 2016, he submitted claims for payment for products he did not actually dispense, in particular one or more of the following products:
  i. Apo‐Diazepam 5mg
  ii. Apo‐Lorazepam 1mg
  iii. Apo‐Oxazepam 30mg
  iv. Hydromorph Contin 12mg
  v. Oxyneo 10mg
  vi. Oxyneo 15mg
  vii. Oxyneo 20mg
  viii. Oxyneo 40mg
  ix. Ratio‐Oxycocet
  x. Sandoz‐Morphine SR 30mg
  xi. Sandoz‐Morphine SR 60mg
  xii. Statex 5mg
  xiii. Tylenol #3
• In or about the period from 1995 to 1999, he sexually abused a patient.

In particular, it is alleged that he

• Sexually abused a patient
• Failed to maintain a standard of practice of the profession
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, s. 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22, and the Notice issued thereunder
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: February 5, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Essa, committed professional misconduct in that

• In or about the period from October 10, 2017 to October 31, 2017, he continued to practise pharmacy despite having been notified that his certificate of registration had been suspended on an interim basis on October 10, 2017.

In particular, it is alleged that he

• Contravened a term, condition or limitation imposed on his certificate of registration
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 143 of the Drug and Pharmacies Regulation Act, RSO 1990, c H.4
• Performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: February 5, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Essa, committed professional misconduct in that he

• Was convicted of sexual assault on October 15, 2018 in the Superior Court of Justice at Cochrane, Ontario

In particular, it is alleged that he

• Was found guilty of an offence that is relevant to his suitability to practice.

Hearing Dates: February 11, 2020, February 12, 2020, February 13, 2020, February 14, 2020, February 20, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Forcucci, while he was a pharmacist, committed professional misconduct in that he

i. Sexually abused a patient, [Name], on one or more occasions;

ii. He failed to maintain professional boundaries by developing and pursuing a personal and/or romantic relationship with [Name] who was a patient at the time;

iii. in the alternative to i and ii, he failed to maintain professional boundaries when he developed and pursued a personal and/or romantic relationship with [Name] in circumstances where he was uncertain as to whether [Name] was a patient;

iv. Behaved in an emotionally abusive manner in respect of his personal relationship with [Name], a patient;

v. Provided benzodiazepines to [Name] without a prescription, or without evidence of a prescription, on one or more occasions;

vi. Interfered with [Name]’s medication management by:

• On one or more occasion, providing [Name] with medication:
  • that had been prescribed to another individual; and/or
  • that was expired; and/or
  • for which he did not have evidence of a prescription; and/or
  • that was contrary to the advice provided by [Name]’s other health care providers; and/or

vii. On one or more occasion, provided [Name] with advice about her prescription medication and health care that was contrary to the advice provided by her other health care providers;

viii. Made disparaging and inappropriate comments to [Name] a patient or former patient about pharmacy students employed by the Pharmacy.

In particular, it is alleged that he

• Sexually abused a patient
• Failed to maintain a standard of profession
• Abused a patient emotionally, verbally or physically
• Contravened a federal law with respect to the distribution, purchase, sale or dispensing or prescribing of any drug, and in particular, s. 5(1) of the Controlled Drugs and Substances Act, SC 1996, s 19, and s. 51 of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217
• Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional

Hearing Dates: March 9, 2020, March 10, 2020, March 11, 2020, March 12, 2020, March 13, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Mourid, while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist at St. Mary Pharmacy, Ontario (“the Pharmacy”) committed professional misconduct in that she

• Submitted and/or permitted, consented to or approved, either expressly or by implication, the submission of, accounts or charges for services that she knew were false or misleading to the Ontario Drug Benefit program through the Pharmacy for:

1. 1. 1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;

• Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of pharmacy records relating to her practice in relation to the dispensing of and/or claims made to the Ontario Drug Benefit program through the Pharmacy for:

1. 1. 1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;

• Failed to ensure that the Pharmacy complied with all legal requirements, including but not limited to, requirements regarding record keeping, documentation, and billing the Ontario Drug Benefit Plan.
• Failed to keep records of monthly Ontario Drug Benefit eligibility cards or a copy of the cards with respect to each person for whom a drug was dispensed, as required by section 29 of Ontario Regulation 201/96, under the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, from on or about October, 2014 to on or about June, 2016
• Submitted to the Ontario College of Pharmacists and/or the Ministry of Health and Long Term Care invoices, receipts and/or other documentation that she knew, or ought to have known, was false, misleading or unreliable to substantiate the purchase and/or transfer of one or more of certain identified drugs and/or products

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting her patients
• Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of records relating to her practice
• Signed or issued, in her professional capacity, and/or permitted, consented to or approved, either expressly or by implication, the signing or issuing of a document that she knew contained a false or misleading statement
• Submitted and/or permitted, consented to or approved the submission of accounts or charges for services that she knew to be false or misleading
• Contravened the Pharmacy Act,1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts and in particular:

1. 1. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended

• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:

1. 1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
   2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended

• Permitted, consented to or approved, either expressly or by implication, the contravention of a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:

1. 1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
   2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended

• Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regarding to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: April 6, 2020, April 7, 2020, April 8, 2020, April 9, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Czilli, on one or more occasions during the period July 3, 2015 to April 1, 2017, while engaged in the practice of pharmacy as owner, Designated Manager and/or dispensing pharmacist at Wellington Apothecary in Windsor, Ontario, committed professional misconduct in that she

• Submitted accounts or charges for services that she knew or reasonably ought to have known were false or misleading to the Ontario Drug Benefit program for MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care;

• Falsified pharmacy records in relation to claims made to the Ontario Drug Benefit Program for MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or,

• Failed to keep records as required in relation to MedsCheck claims made to the Ontario Drug Benefit Program.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession
• Falsified records relating to her practice
• Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement
• Submitted an account or charge for services that she knew was false or misleading statement
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular sections 20 and 21 of Ontario Regulation 264/16
• Failed to keep records as required
• Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: May 4, 2020, May 5, 2020,

Summary of Allegations

Following a hearing on February 11-15, 2019, a Panel of the Discipline Committee made findings of professional misconduct against Ms. Bijanzadeh in a decision dated September 17, 2019, in that she:

• Failed to exercise appropriate professional diligence with respect to the dispensing of narcotics, which resulted in her filling forged prescriptions purportedly written by [Physician A]. and/or [Physician B] without making appropriate inquiries.

In particular, the Panel found that she

• Failed to maintain a standard of practice of the profession;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or section 40 of O.Reg. 58/11, R.S.O. 1990, c.H.4;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section 31 of the Narcotic Control Regulations, C.R.C., c.1041, as amended, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as dishonourable and unprofessional.

Submissions with respect to Order will be heard on May 4 and 5, 2020.

Hearing Dates: May 6, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist in Ottawa, Ontario, committed professional misconduct in that he

• Engaged in the trafficking of controlled substance with respect to certain identified items
• Dispensed drugs and/or products for which prescriptions are legislatively required without an authorized prescriber’s authorization as set out for certain identified items
• In or about the period from January 2013 to March 2015, he failed to keep records as required by the Medication Procurement and Inventory Management Policy with respect to the inventory of narcotics and controlled drugs
• Submitted accounts or charges for services that he knew were false or misleading to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
• Falsified pharmacy records relating to his practice in relation to claims made to the Ontario Drug Benefit program for one or more certain identified drugs and/or drug products
• From approximately January 2013 to March 2015, he used his position as pharmacist to traffic in narcotics, in particular fentanyl patches
• Procured an individual to carry out a simulated robbery of the IDA Rideau Pharmacy on October 26, 2014
• Made a report to the […] Police in respect of a robbery allegedly committed on October 26, 2014, knowing that the report was false

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting his patients
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement with respect to the certain identified forged prescriptions
• Submitted accounts or charges for services that he knew to be false or misleading
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts with respect to the following incidents:
  • Dispensing drugs and/or products in the absence of a prescription authorized by a prescriber in contravention of s. 40 of Ontario Regulation 58/11 under the Drug and Pharmacies Regulation Act and ss. 155 and 156
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, and in particular, with respect to the following incidents:
  • Trafficking controlled substances in contravention of s. 5 of the Controlled Drugs and Substances Act
  • Dispensing drugs in the absence of a prescription authorized by a prescriber in contravention of s. 31 of the Narcotic Control Regulation
  • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of C.01.041 of the Food and Drug Regulations
  • Selling drugs in the absence of a prescription authorized by a prescriber in contravention of G.03.002 of the Food and Drug Regulations
• Knowingly permitted the premises in which the pharmacy was located to be used for unlawful purposes
• Permitted, consented to or approved, either expressly or by implication, the commission of an offence against any Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: May 6, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen committed professional misconduct in that he

• Failed to comply with the decision of the Inquiries, Complaints and Reports Committee dated May 10, 2016, in that he failed to successfully complete the Professional Problem-Based Ethics workshop offered by the Center for Personalized Education for Physicians, at his own expense, within 12 months of the date of that decision, and provide proof thereof to the College.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, namely: he contravened s. 26(3) of the Health Professions Procedural Code
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: May 6, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shaheen, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager, shareholder and/or director at IDA Rideau Medical Pharmacy in Ottawa, Ontario, between May 2, 2011 and June 17, 2015, committed professional misconduct in that he

• Falsified pharmacy records relating to his practice in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims;
• Submitted an account or charge for services that he knew was false or misleading in connection with claims made for certain identified drugs and/or other products and/or certain identified MedsCheck claims

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified pharmacy records relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15(1) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10, as amended
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: May 12, 2020, May 13, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner at the MT Cross Pharmacy, Greenhill Pharmacy, and/or I-Care Drug Mart, all in Hamilton, Ontario, committed professional misconduct in that he

• Submitted (or permitted the submission of) unsubstantiated billings to third party payors, in respect of certain identified products.
• Failed to keep records as required respecting his patients or practice with respect to certain identified prescriptions.
• Operated or permitted the MT Cross Pharmacy to operate on or about March 28, 2018, without the supervision of a pharmacist who is physically present.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting his patients or practice
• Falsified a record in relation to his practice
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading
• Contravened s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: May 12, 2020, May 13, 2020,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner at the MT Cross Pharmacy in Hamilton, Ontario, in the period from about June 27, 2017, to May 16, 2018, committed professional misconduct in that he

• Failed to take all reasonable steps to keep the Pharmacy”™s narcotic and controlled drugs inventory secure against loss and theft;
• Failed to conduct physical counts and reconciliations of narcotic and controlled drugs inventory as required by the College policy entitled “Medication Procurement and Inventory Management”;
• Failed to keep adequate records in relation to the Pharmacy”™s inventory of narcotics and controlled drugs;
• Failed to ensure that delivery slips for deliveries of narcotics and controlled drugs were signed by the patients to whom they were delivered.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting his practice
• Contravened s. 152(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4
• Contravened a federal or provincial law with respect to the distribution, purchase, sale, or dispensing or prescribing of drugs, in particular ss. 30 and 43 of the Narcotic Control Regulations, C.R.C., c. 1041.
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe committed professional misconduct in that she:

• Failed to fulfill all requirements related to working with a practice mentor, as ordered by the Discipline Committee on December 8, 2016.

In particular, it is alleged that she

• Contravened a term, condition or limitation imposed on her certificate of registration;
• Failed to comply with an order of a panel of a Committee of the College;

• Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe, while practising as a pharmacist, Designated Manager and/or the sole director and shareholder of the corporation that owned and operated Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario, committed professional misconduct in that she

• Engaged in the practice of pharmacy while her certificate was suspended from on or around December 1, 2018 to on or around January 31, 2019;
• Falsified records relating to her practice or a person’s health record with respect to one or more identified prescriptions from on or about December 1, 2018 to on or about January 31, 2019;
• Kept medications in inventory without expiration dates and/or lot numbers, in or around February of 2019.

In particular, it is alleged that she

• Contravened a term, condition or limitation imposed on her certificate of registration;
• Failed to comply with an order of a panel of a Committee of the College;
• Practised the profession while her certificate was under suspension;
• Falsified records relating to her practice or a person’s health record;
• Failed to maintain a standard of practice of the profession;
• Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Abdou, as a pharmacist at Martindale IDA Pharmacy in St. Catharines, Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he

• Submitted claims to [Insurance Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about March 2017-March 2018

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Charged a fee that was excessive in relation to the service provided
• Charged a fee or amount that was excessive in relation to the service or product provided
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Al-Sakaff, while he was the Designated Manager, as well as a director and shareholder of the owner of Cannon Pharmacy in Hamilton, Ontario (the “Pharmacy”), committed professional misconduct in that:

• Between November 2015 and February 2017, he employed in the Pharmacy a pharmacist whose certificate of registration had been revoked for cause; and/or
• On more than one occasion between November 2015 and February 2017:
  • he permitted, consented to or approved, either expressly or by implication, the operation of the Pharmacy without a pharmacist present; and/or
  • he permitted, consented to or approved, either expressly or by implication, the dispensing and/or sale of a drug by an unauthorized person; and/or
  • he signed a hardcopy for a prescription in circumstances where he did not dispense the medication.

In particular, it is alleged that he

• Failed to maintain the standards of practice of the profession;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
• Contravened the Drug and Pharmacies Regulation Act (DRPA), and in particular:
  • s. 143(a) of the DPRA,
  • s. 146(1)(a) of the DPRA, and/or
  • s. 149 of the DPRA;
• Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Aziz, as pharmacist and Designated Manager at The Medicine Shoppe, Toronto, Ontario (the “Pharmacy”), and/or as director of the corporate owner of the Pharmacy, committed professional misconduct in relation to orders processed from Meds Via Canada, in or about 2013-2017, in that he

• Sold by retail and/or dispensing prescription drugs to patients in the U.S. without a lawful and/or otherwise valid prescription; and/or
• Contravened the OCP Policy on Prescriptions – Out of Country, dated January-February 2003.

In particular, it is alleged that he

• Failed to maintain a standard of practice of a profession;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 158 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-4, as amended;
• Contravened, while engaged in the practise of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections C.01.041 and/or C.01.042 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Bebawy, as dispensing pharmacist and/or Designated Manager at The Medicine Shoppe in Peterborough, Ontario (the “Pharmacy”), and/or as director and majority shareholder of the corporation that owned and operated the Pharmacy, committed professional misconduct, in or about 2018-2019, in that she

• Failed to ensure all blister pack prescriptions were checked and/or signed by the pharmacist dispensing the prescriptions to patients, including for certain identified patients;
• Failed to ensure the prescriptions and/or contents of blister pack prescriptions were recorded accurately for patients, including for certain identified patients;
• Failed to ensure compliance with the OCP guideline on Multi-Medication Compliance Aids, updated 2013, with respect to billing, dispensing and/or documenting blister pack prescriptions;
• Billed routinely for excessive dispensing fees at weekly intervals for blister pack prescriptions actually dispensed to patients at bi-weekly or monthly intervals, including for certain identified patients; and/or
• Creatd false and/or misleading records routinely indicating blister pack prescriptions were being dispensed to patients at weekly intervals when the prescriptions were actually being dispensed to patients at bi-weekly or monthly intervals, including for certain patients.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession
• Failed to provide an appropriate level of supervision to a person whom she was professionally obligated to supervise
• Failed to keep records as required respecting her patients or practice
• Falsified a record relating to her practice or a person’s health record
• Submitted an account or charge for services or products that she knew or ought to have known was false or misleading
• Charged a fee or amount that was excessive in relation to the service or product provided
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, section 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H. 4; section 20 of O.Reg. 264/16; sections 4, 4.1, 5, and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c. O. 10; and/or sections 18, 20.2 and/or 27 of O.Reg. 201/96, as amended
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Billings committed professional misconduct in that

• on July 18, 2016 in the Ontario Court of Justice at Lindsay, Ontario, he was found guilty of one count of use of a forged document, contrary to Section 368(1)(a) of the Criminal Code of Canada; and one count of fraud not exceeding $5,000.00, contrary to Section 380(1)(b) of the Criminal Code of Canada;
• beginning in January 2012 and continuing to February 1, 2016 he self-prescribed medication, by filling out prescriptions for himself and signing the name of his previous family doctor on theprescriptions.

In particular, it is alleged that he

• was found guilty of offenses that are relevant to his suitability to practice;
• dispensed or sold drugs for an improper purpose;
• falsified a record relating to his practice;
• engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Castillo, while employed as a pharmacist, committed professional misconduct in that she

• Failed to maintain the professional boundaries of the pharmacist-patient relationship when you developed and engaged in a non-professional, personal relationship with the patient, [Name], from in or about March 2017 toin or about April 2018; and/or

• Engaged in sexual abuse of the patient, [Name], on one or more occasions, from in or about March 2017 to in or about April 2018.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession;
• Abused a patient emotionally, verbally or physically;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shereen El-Azrak committed professional misconduct in that

• On September 25, 2018, in the Superior Court of Justice at Newmarket, she was found guilty of trafficking in fentanyl and possession of fentanyl for the purpose of trafficking, contrary to s. 5 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19.

In particular, it is alleged that she

• Was found guilty of offences that are relevant to her suitability to practice.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Fakoori, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Yonge Cummer Pharmacy in North York, Ontario and/or director, shareholder, owner, and/or dispensing pharmacist at Aurora Pharmacy in Aurora, Ontario, committed professional misconduct in that he

• Failed to keep records as required respecting his patients and/or practice with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017;
• Falsified a record relating to his practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017; and/or
• Submitted an account or charge for services that he knew or ought to have known was false and misleading with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act, and
  • sections 18, 19, and 20 of Ontario Regulation 264/16;
• Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act, and
  • sections 18, 19, and 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ghobrial, as staff pharmacist and/or Designated Manager at Ancaster Village Pharmacy in Ancaster, Ontario (“Pharmacy”), and a shareholder of the corporation that owned and operated the Pharmacy, committed professional misconduct in that he

• Submitted false or unsubstantiated claims for medications and/or health supplies not requested by and/or not dispensed to certain identified patients; and/or
• Created false records in relation to claiming for medications and/or health supplies not requested by and/or dispensed to certain identified patients.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice and/or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services and/or products that he knew and/or ought to have known was false or misleading;
• Charged a fee and/or amount that was excessive in relation to the service and/or product provided; and/or
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Girgis Boktor, as pharmacist at Ancaster Village Pharmacy in Ancaster, Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he

• Submitted claims to [Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about February 2017-February 2018.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Charged a fee that was excessive in relation to the service provided
• Charged a fee or amount that was excessive in relation to the service or product provided
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Guerguis, as a pharmacist and/or Designated Manager at Martindale IDA Pharmacy in St. Catharines, Ontario, committed professional misconduct in that he

• Submitted claims to [Insurance Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about March 2017-March 2018

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Charged a fee that was excessive in relation to the service provided
• Charged a fee or amount that was excessive in relation to the service or product provided
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

• Charged an excessive fee to patient [Name] in relation to her prescription for Nabilone 0.5mg/ml

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Charged a fee or amount that was excessive in relation to the service or product provided
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

• Charged an excessive fee in relation to the prescription of patient [Name] for Ziprasidone 15mg;
• Failed to inform the parents of patient [Name] of less expensive ways in which the same medication could be prepared

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Charged a fee or amount that was excessive in relation to the service or product provided
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Johnel Henry, while employed as a pharmacy technician, committed professional misconduct in that she

• Failed to maintain the professional boundaries of the pharmacy technician-patient relationship when she developed and engaged in a non-professional, personal relationship with the patient, [Name], from in or about July 2017 to in or about June 2019; and/or
• Engaged in sexual abuse of the patient, [Name], on one or more occasions, from in or about July 2017 to in or about June 2019.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession;
• Abused a patient emotionally, verbally or physically;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Iskandar, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Clinic Pharmacy in Midland, and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that:

• Between about January 9, 2013 and March 28, 2017, she failed to actively and effectively participate in and/or monitor the day-to-day management of the Pharmacy, including, but not limited to drug procurement and inventory management, record keeping and documentation, billing, and staff and personnel management, and/or she failed to actively and effectively fulfill the duties and responsibilities of a Designated Manager;
• Between about January 9, 2013 and March 28, 2017, she operated (or permitted, consented to or approved, expressly or impliedly, the operation of) the Pharmacy when it was not managed by a pharmacist who was designated as the Designated Manager of the Pharmacy;
• Between about June 16, 2016 and March 28, 2017, she failed to ensure that her name, certificate of registration, or both were clearly and publicly displayed in the Pharmacy;
• On or about January 9, 2013, she signed an Acknowledgment/Change of Designated Manager form containing a false or misleading statement by indicating that “[A.N.]” did not continue to work at the Pharmacy;
• Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
• Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
• Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
• Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
• Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the provision of routine pharmaceutical care to family members including herself and/or one or more of [family members] by [person] as dispensing pharmacist;
• Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the selling of certain identified prescription drugs and/or products without valid prescriptions;
• Between about June 2015 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
• Between about June 2015 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to her practice;
• Signed or issued in her professional capacity a document that she knew contained a false or misleading statement;
• Submitted an account or charge for services that she knew was false or misleading
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
  • s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • s. 146(3) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
  • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
  • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
• Permitted, consented to or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which she was a director;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Khan, while engaged in the practice of pharmacy as a dispensing pharmacist at Shoppers Drug Mart, located at 300 Taunton Road East in Oshawa (“SDM Taunton”) and/or at Shoppers Drug Mart located at 20 Warren Road in Oshawa (“SDM Warren”), committed professional misconduct in that she

• Was found guilty of an offence that is relevant to her suitability to practise with respect to findings of guilt made on December 18, 2017, by the Ontario Court of Justice at Oshawa in relation to the following counts:

• • Theft of Oxycocet exceeding $5,000, contrary to section 334(a) of the Criminal Code of Canada;
  • Fraud with respect to Oxycocet exceeding $5,000, contrary to section 380(1)(a) of the Criminal Code of Canada;
  • Theft of Oxycocet not exceeding $5,000, contrary to section 334(b) of the Criminal Code of Canada; and/or
  • Fraud with respect to Oxycocet not exceeding $5,000, contrary to section 380(1)(b) of the Criminal Code of Canada;

• In the period from in or about February 17, 2017, to April 29, 2017, she misappropriated at least 11,830 tablets of Ratio-Oxycocet and/or Sandoz-Oxycodone Acetaminophen, without authorization or record, from SDM Taunton;
• In the period from in or about April 5, 2016, to December 10, 2016, she misappropriated at least 78,045 tablets of Ratio-Oxycocet, without authorization or record, from SDM Warren;
• In the period from in or about February 17, 2017, to April 29, 2017, she submitted approximately 28 false claims, for which there were no valid prescriptions and for which payment was not required, to the Ontario Drug Benefit program (“ODB”) from SDM Taunton; and/or
• In the period from in or about April 5, 2016, to December 10, 2016, she submitted approximately 304 false claims, for which there were no valid prescriptions and for which payment was not required, to the ODB from SDM Warren.

In particular, it is alleged that she

• Was found guilty of an offence that is relevant to her suitability to practice;
• Failed to maintain a standard of practice of the profession;
• Dispensed or sold drugs for an improper purpose;
• Failed to keep records as required respecting her patients;
• Falsified a record relating to her practice;
• Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement;
• Submitted an account or charge for services that she knew was false or misleading
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
  • Section 155 of the Drug and Pharmacies Regulation Act
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • Sections C.01.041, G.03.002, and/or G.03.012 of the Food and Drug; Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S,C. 1985, c. F-27, as amended;
  • Section 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
  • Section 31 of the Narcotic Control Regulations, C.R.C., c. 1041, as amended, to the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
  • Section 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22, as amended, and the Notice issued thereunder, and/or section 11 of the Narcotic Safety and Awareness Act, 2010, S.O. 2010 C.22, as amended;
  • Section 15 of the Ontario Drug Benefit Act, R.S.O. 1990, C.0.10, as amended;
  • Sections 334(a), 334(b), 380(1)(a), and/or 380(1)(b) of the Criminal Code of Canada;
• Knowingly permitted the premises in which a pharmacy was located to be used for unlawful purposes;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Nimet Lalji, from in or about May 2015 to in or about April 2017, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Express Aid I.D.A. Pharmacy (the “Pharmacy”) in Barrie, Ontario, committed professional misconduct in that she

• Submitted false, misleading, inaccurate, and/or unsubstantiated claims to the Ontario Drug Benefit Program for one or more of certain identified drugs and/or products and/or one or more of certain identified claims; and/or
• Failed to keep records as required with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims submitted to the Ontario Drug Benefit Program;
• Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting her patients;
• Falsified a record relating to her practice;
• Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that she knew or ought to have known was false or misleading;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • sections 155, 156, and 166 of the Drug and Pharmacies Regulation Act, as amended;
  • section 20(1) of Ontario Regulation 264/16, as amended; and
  • section 54(1) of Ontario Regulation 58/11, as amended;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • sections 155, 156, and 166 of the Drug and Pharmacies Regulation Act, as amended;
  • section 20(1) of Ontario Regulation 264/16, as amended;
  • section 54(1) of Ontario Regulation 58/11, as amended;
  • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
  • sections 18, 19, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Lin, while engaged in the practice of pharmacy as owner and/or dispensing pharmacist at the Life Compounding Pharmacy in Richmond Hill, Ontario, in or about the period from December 5, 2016 to December 31, 2018, committed professional misconduct in that he

• Conducted sterile compounding of atropine eye drops at a facility not accredited for that purpose;
• Kept products in the compounding area that were expired and/or not properly labelled;
• Failed to keep the compounding area in an acceptable state of cleanliness and organization;
• Failed to keep records as required in respect of certain identified cancelled prescriptions.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Contravened sections 139 and 146 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ma, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, committed professional misconduct in that he:

• Dispensed monitored drugs without acting on Narcotic Monitoring System alerts for one or more of certain identified prescriptions;

• Dispensed monitored drugs without documenting the actions taken, and/or the reason(s) for not taking any action, in response to Narcotic Monitoring System alerts for one or more of certain identified prescriptions; and/or,

• Dispensed one or more of certain identified prescriptions without labelling the container in which the drug(s) was dispensed.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;

• Failed to keep records as required respecting his patients and/or practice;

• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
  • Sections 156 and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and/or
  • Section 54 of Ontario Regulation 58/11;

• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Guo Ma, from in or about March 2015 to in or about November 2017, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, Ontario, committed professional misconduct in that he

• Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products;
• Submitted an account or charge for services that he knew was false or misleading with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
• Falsified a record relating to his practice with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
• Signed or issued, in his professional capacity, a document he knew contained a false and misleading statement with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program; and/or,
• Failed to keep records as required respecting his patients with respect to:
  1. one or more of certain identified drugs and/or products; and/or,
  2. one or more of certain identified claims to the Ontario Drug Benefit Program.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 156, 163, and 166 of the Drug and Pharmacies Regulation Act, as amended;
  • section 20(1) of Ontario Regulation 264/16, as amended;
  • sections 40 and 54(1) of Ontario Regulation 58/11;
  • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
  • sections 18, 19, 25, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
• Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
  • sections 155, 156, 163, and 166 of the Drug and Pharmacies Regulation Act, as amended;
  • section 20(1) of Ontario Regulation 264/16, as amended;
  • sections 40 and 54(1) of Ontario Regulation 58/11, as amended;
  • sections 5, 6, 15(1), 17(2), and/or 23(1) of the Ontario Drug Benefit Act, as amended; and/or
  • sections 18, 19, 25, 27, and/or 29(1) of Ontario Regulation 201/96, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Christopher MacDonald, while engaged in the practice of pharmacy at the […] Pharmacy in […], on or about December 1, 2018, committed professional misconduct in that he

• Engaged in sexual touching of [Name] without consent.

In particular, it is alleged that he

• Sexually abused a patient, [Name];
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional;
• Engaged in conduct unbecoming a pharmacist.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Shaukatali Mangalji, committed professional misconduct in that he

• Failed to adequately supervise pharmacy assistants in the preparation of methadone and/or buprenorphine doses, and in doing so failed to comply with the National Association of Pharmacy and Regulatory Authorities Model Standards of Practice for Pharmacists;
• Improperly delegated responsibility for supervising the administration of methadone and/or buprenorphine doses to pharmacy assistants, and in doing so failed to comply with CAMH’s Opioid Agonist Maintenance Treatment: A Pharmacist’s Guide to Methadone and Buprenorphine for Opioid Use Disorder, and/or the Ontario College of Pharmacists’ Fact Sheet: Key Requirements for Methadone Dispensing as required by the Ontario College of Pharmacists’ Opioid Policy;
• Failed to adequately supervise pharmacy assistants [Person A] and/or [Person B] and/or [Person C] in the preparation of methadone doses for patients [Patient 1] and/or [Patient 2] and/or [Patient 3] and/or [Patient 4], from on or about January 3, 2019, to on or about May 30, 2019; and/or
• Signed the patient methadone logs of patients [Patient 1] and/or [Patient 2] and/or [Patient 3] and/or [Patient 4], indicating that he had observed the administration of their methadone doses when he had not, from on or about January 3, 2019, to on or about May 30, 2019, and/or he signed a daily dose log indicating he observed the administration of a buprenorphine dose for patient [Patient 5] on or about July 25, 2019, when he had not.

In particular, it is alleged that he:

• Failed to maintain standards of practice of the profession;
• Failed to provide an appropriate level of supervision to persons for whom he was professionally obligated to supervise;
• Falsified records relating to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. McAnulty committed professional misconduct in that he

• Was employed in or worked in Tom’s Pharmacy while his licence was suspended for cause;
• Used the title “pharmacist” while his certificate of registration was suspended, including but not limited to: on his LinkedIn profile; when quoted in an article in the Toronto Star on or about December 22, 2017; when calling in to a radio show on or about September 4, 2018; and/or in interactions with patients and the public at Tom’s Pharmacy;
• Dispensed or sold drugs at Tom’s Pharmacy when he was not a pharmacist, in particular but not limited to on or about October 20, 2017, February 22, 2018, and/or September 15, 2018;
• Engaged in the controlled acts of prescribing, dispensing, selling or compounding a drug as defined in the Drug and Pharmacies Regulation Act, or supervising the part of the pharmacy where such drugs are kept at Tom’s Pharmacy, when he was not a member authorized by a health profession Act to perform the controlled act, in particular but not limited to on or about October 20, 2017, February 22, 2018, and/or September 15, 2018;
• Provided information or education to patients at Tom’s Pharmacy, in particular but not limited to [Patient A] on or about February 20, 2018, [Patient B] in or after August 2018, and other customers on or about September 15, 2018;
• Provided instructions regarding the dispensing of extra tablets of sildenafil to [Patient C] in or around August 2018 to October 2018;
• Removed prescription drugs from Tom’s Pharmacy without a prescription, including but not limited to Lynparza and Premarin;
• Sold drugs without a prescription, including but not limited to Lynparza and Premarin
• Engaged in certain conduct at [Pharmacy 1] and/or [Pharmacy 2] on or about March 7, 2018; and/or
• Demonstrated a pattern of ungovernability

In particular, it is alleged that he

• Inappropriately used a term, title or designation in respect of his practice
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, in particular but not limited to:
  • subsection 10(1) of the Pharmacy Act
  • section 10(2) of the Pharmacy Act
  • section 143 of the Drug and Pharmacies Regulation Act
  • section 149 of the Drug and Pharmacies Regulation Act
  • section 155 of the Drug and Pharmacies Regulation Act
  • section 27 of the Regulated Health Professions Act, 1991
• Contravened any federal, provincial or territorial law or municipal by-law, with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote public health, or that is otherwise relevant to his suitability to practice, in particular but not limited to subsection C.01.041 of the Food and Drug Regulations, C.R.C., c. 870
• Failed to comply with an order of a Committee or a panel of a Committee of the College, namely the interim suspension order of the Inquiries, Complaints and Reports Committee, effective as of June 30, 2017
• Practised the profession while his certificate of registration was under suspension
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional
• Engaged in conduct that is unbecoming a member

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. McAnulty committed professional misconduct in that he:

• Failed to successfully complete, at his own expense, the ProBE Program on Professional/Problem Based Ethics for healthcare professionals, with an unconditional pass, within twelve (12) months of the date of the Order made by a panel of the Discipline Committee on or about March 29, 2018;
• Held himself out as a person who is qualified to practise in Ontario as a pharmacist while his certificate of registration was suspended, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019;
• Was employed in or worked in Tom’s Pharmacy while his licence was suspended for cause, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019;
• Engaged in the practice of pharmacy at Tom’s Pharmacy while his certificate of registration was suspended, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019;
• Interacted with patients or customers at Tom’s Pharmacy while his certificate of registration was suspended, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019; and/or
• Demonstrated a pattern of ungovernability.

In particular, it is alleged that he:

• Contravened a term, condition or limitation imposed on his certificate of registration;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, in particular but not limited to:
  • section 10(2) of the Pharmacy Act; and/or
  • section 143 of the Drug and Pharmacies Regulation Act;
• Failed to comply with an order of a Committee or a panel of a Committee of the College;
• Practised the profession while his certificate of registration was under suspension;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and/or Designated Manager at Pars Medical Pharmacy in Richmond Hill, committed professional misconduct in that he

• Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
• Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
• Obtained new prescriptions and/or prescription refills for himself for certain identified prescriptions;
• Dispensed prescription medications to himself in relation to certain identified prescriptions; and/or
• Submitted claims to [Insurer] for 200 diabetic test strips for himself on or about October 27, 2014, as though the prescription had been authorized by him in accordance with the regulations under the Pharmacy Act, 1991 which was not accurate, and/or then falsified a record retroactively to indicate that the claim had been authorized by a physician before being submitted.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Practised the profession while he was in a conflict of interest
• Failed to keep records as required respecting his patients
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and Designated Manager at Pars Medical Pharmacy in Richmond Hill, Ontario, and as shareholder of Ultra Care Pharmacy Inc., the owner and operator of the Pharmacy, committed professional misconduct in that he

• Submitted false or unsubstantiated claims to the Ontario Drug Benefit Program totalling approximately $80,000.00 in relation to nine identified drug and/or other health products in or about January 2013-March 2015; and/or
• Created false records of billing and/or dispensing transactions in relation to the false or unsubstantiated claims submitted to the Ontario Drug Benefit Program in relation to nine identified drug and/or other health products in or about January 2013-March 2015

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified a record relating to his practice
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
• Submitted an account or charge for services that he knew was false or misleading
• Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Ontario Drug Benefit Act, R.S.O. 1990 c.O. 10, sections 5, 6 and/or 15, as amended, and/or Ontario Regulation 201/96, section 27
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Musitano, as dispensing pharmacist and/or Designated Manager at Concession Medical Pharmacy in Hamilton, Ontario, committed professional misconduct, in or about 2016-2019, in that she:

• Sold and/or dispensed certain identified prescription drugs to the patient, [Patient], without lawful or otherwise valid prescriptions;
• Failed to keep records as required regarding certain identified prescription drugs dispensed to the patient, [Patient];
• Falsified records regarding certain identified prescription drugs dispensed to the patient, [Patient]; and/or
• Contravened the OCP policy on Prescriptions – Out of Country, dated January-February 2003, with respect to entering into an agreement or otherwise facilitating the practice of Dr. [Name] to re-issue prescriptions for the patient, [Patient], despite not having any substantive professional relationship with the patient, in relation to certain identified transactions.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession

• Failed to provide an appropriate level of supervision to a person whom she was professionally obligated to supervise, including other pharmacist and non-pharmacist staff at the Pharmacy
• Failed to keep records as required
  • respecting her patients (for conduct up to and including May 4, 2017); and/or
  • respecting her patients or practice (for conduct on or after May 5, 2017)
• Falsified a record
  • relating to her practice (for conduct up to and including May 4, 2017), and/or
  • relating to her practice or a person’s health record (for conduct on or after May 5, 2017)
• Signed or issued, in her professional capacity, a document
  • that she knew contained a false or misleading statement (for conduct up to and including May 4, 2017), and/or
  • that she knew or ought to have known contained a false or misleading statement (for conduct on or after May 5, 2017)
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular,
  • sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended,
  • sections 54, 55, 56 and/or 57 of Ontario Regulation 58/11, as amended, and/or
  • sections 20 and/or 21 of Ontario Regulation 264/16, as amended (for conduct up to an including May 4, 2017), and/or
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
  • sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or
  • sections 20 and/or 21 of Ontario Regulation 264/16, as amended (for conduct on or after May 5, 2017)
• Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular,
  • sections C.01.041, C.01.042 and/or C.01.042.1 of the Food and Drug Regulations, C.R.C., c 870, as amended (for conduct up to and including May 4, 2017), and/or
• Contravened any federal, provincial or territorial law or municipal by-law,

1. with respect to the distribution, purchase, sale or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis,
2. whose purpose is to protect or promote public health, or
3. that is other relevant to the member’s suitability to practise,

and in particular,

• • sections C.01.041, C.01.042 and/or C.01.042.1 of the Food and Drug Regulations, C.R.C., c 870, as amended (for conduct on or after May 5, 2017)

• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Umair Nasim committed professional misconduct with respect to

• The finding of guilt made on April 17, 2019 by the Ontario Court of Justice at Hamilton in relation to the following count: that on or about the 16th day of January in the year 2018 at the City of Hamilton, he did contravene sections 30, 42 and 43 of the Narcotic Control Regulations, sections G.03.001(1), G.03.012 and G.03.013 of the Food and Drug Regulations, and sections 7(1)(b) and 50 of the Benzodiazepines and Other Targeted Substances Regulations, thereby committing an offence contrary to section 46 of the Controlled Drugs and Substances Act.

In particular, it is alleged that he

• Was found guilty of an offence that is relevant to his suitability to practice.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Umair Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, Designated Manager and/or owner at the MT Cross Pharmacy in Hamilton, Ontario, in the period from about June 27, 2017 to May 16, 2018, committed professional misconduct in that he

• Submitted (or permitted the submission of) unsubstantiated billings to third party payors, in respect of the following products: Apo-Cinacalcet 60mg tablets, Apo-Cinacalcet 90mg tablets, Maxalt 10mg tablets, Maxalt RPD 10mg wafers, and/or Apo-Eletriptan 40mg tablets.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Falsified a record in relation to his practice;
• Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasr, while engaged in the practice of pharmacy at Clinic Pharmacy in Midland, committed professional misconduct in that:

• Between about January 9, 2013 and March 28, 2017, he failed to provide and/or update the Ontario College of Pharmacists with the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
• Between about January 9, 2013 and March 28, 2017, he submitted annual renewal certificates and/or information to the College that were/was inaccurate with respect to the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
• Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
• Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
• Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
• Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
• Between about June 2015 and December 2016, he provided and/or purported to provide routine pharmaceutical care to family members including [family members], and/or including himself as patient;
• Between about June 2015 and December 2016, he signed certain identified prescription hardcopies as dispensing pharmacist, for ostensible prescriptions for family members including [family members], and/or including himself as patient, but that were not valid prescriptions;
• Between about June 2015 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
• Between about June 2015 and December 2016, he sold (or permitted, consented to or approved, expressly or impliedly, the sale of) certain identified prescription drugs and/or products without valid prescriptions;
• Between about June 2015 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice;
• Signed or issued in his professional capacity a document that he knew contained a false or misleading statement;
• Submitted an account or charge for services that he knew was false or misleading;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
  • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
  • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
  • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Peters, while employed as a pharmacy technician at Muxlow Pharmacy in Meaford, Ontario committed professional misconduct in that

• On or about December 1, 2016, he stole fentanyl patches from the Pharmacy
• On February 8, 2018 findings of guilt were made against him by the Ontario Court of Justice at Owen Sound, Ontario in relation to the following counts:
  • Theft under $5000 (fentanyl), contrary to s. 334(b) of the Criminal Code;
  • Possession of cocaine, contrary to s. 4(1) of the Controlled Drugs and Substances Act;
  • Possession of hydromorphone, contrary to s. 4(1) of the Controlled Drugs and Substances Act.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Dispensed drugs for an improper purpose
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional
• Was found guilty of offences that are relevant to his suitability to practise

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Politis, from in or about November 17, 2015, to in or about December 2015, while engaged in the practice of pharmacy as owner, Designated Manager and/or pharmacist at Peoples Pharmacy in Toronto, Ontario (the “Pharmacy”),committed professional misconduct in that he:

• Conducted MedsCheck At Home reviews that were not adequate, for multiple patients;
• Failed to properly document MedsCheck At Home reviews, for multiple patients;
• Submitted, or had staff submit, accounts or charges for services to the Ontario Drug Benefit program for MedsCheck At Home reviews that were non-compliant with the guidelines of the Ministry of Health and Long Term Care, including guidelines regarding timeliness of claims.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients;
• Engaged in conduct that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Popoola committed professional misconduct in that she:

• Failed to maintain personal professional liability insurance from approximately January 2016 to approximately March 24, 2019 while maintaining her registration in Part A of the Register;
• Made false statements respecting her personal professional liability insurance when she renewed her registration in Part A of the Register on or about March 7, 2016, March 9, 2017, and March 9, 2018; and
• Made false statements respecting her provision of at least 600 hours of patient care over the preceding three years while practising the profession of pharmacy when she renewed her registration in Part A of the Register on or about March 9, 2018 and April 8, 2019.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Signed or issued, in her professional capacity, documents that she knew and/or ought to have known contained false or misleading statements;
• Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Roufaiel, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at Southdale Pharmacy in London, Ontario, committed professional misconduct in that he

• Failed to properly complete Destruction Request Forms dated March 6, 2017, November 29, 2016, November 18, 2016 and/or an undated form;
• Failed to maintain accurate records of purchases, sales and remaining inventory for narcotics, controlled drugs and/or targeted substances;
• Failed to make timely reports of losses of narcotics, controlled drugs and/or targeted substances to Health Canada during the period March 21, 2015 to April 5, 2017; and/or
• Failed to take all reasonable steps necessary to protect and secure narcotics, controlled drugs and targeted substances, including:
  • Failing to conduct and/or document narcotic inventory counts including narcotic reconciliations at least every six months during the period March 21, 2015 – March 21, 2017 and/or to maintain the results of the inventory counts for a two-year period;
  • Discrepancies in the inventory of narcotics, controlled drugs and/or targeted substances, as recorded in inventory counts conducted January 20, 2017, March 13, 2017 and/or March 22, 2017; and/or
  • Failing to report the loss, theft or forgery related to narcotics, controlled drugs and/or targeted substances in a timely way to Health Canada following inventory counts on January 20, 2017, March 13, 2017, and/or March 22, 2017.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Failed to keep records respecting his patients;
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs including:
  • The Narcotic Control Regulations, sections 30, 40, 42 and/or 43, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19; and/or
  • The Food and Drug Regulations, sections G.03.001, G.03.004, G.03.007, G.03.010, G.03.012, G.03.013 and/or G.03.015, under the Food and Drugs Act, R.S.C. 1985 c.F-27;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that George Roufaiel, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at Southdale Pharmacy in London, Ontario, committed professional misconduct in that he

• Failed to sign approximately 55 prescription hardcopies processed on January 3, 2018;
• Failed to ensure that a stock bottle contained only one brand of alprazolam 0.5 mg on January 15, 2018;
• Failed to take all reasonable steps necessary to protect and secure narcotics, controlled drugs and/or targeted substances during the period March 23, 2017 to January 30, 2018, including:
  • Discrepancies in the inventory of narcotics, controlled drugs and/or targeted substances, as recorded in inventory counts conducted October 2, 2017, October 27, 2017, November 30, 2017, an unknown date, and/or January 15, 2018;
  • Failing to conduct narcotic inventory counts including narcotic reconciliations at least every six months and/or to maintain the results of the inventory counts for a two-year period;
  • Failing to maintain accurate records as required of purchases, sales and remaining inventory for narcotics, controlled drugs and/or targeted substances; and/or
  • Failing to make timely reports of destruction or losses of narcotics, controlled drugs and/or targeted substances to Health Canada.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Failed to keep records as required respecting his patients and/or practice
• Contravened any federal, provincial or territorial law or municipal by-law with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote public health or that is otherwise relevant to his suitability to practise including
  • The Narcotic Control Regulations, sections 30, 40, 42 and/or 43, under the Controlled Drugs and Substances Act, S.C. 1996, c. 19; and/or
  • The Food and Drug Regulations, sections G.03.001, G.03.004, G.03.007, G.03.010, G.03.012, G.03.013 and/or G.03.015, under the Food and Drugs Act, R.S.C. 1985 c.F-27; and/or
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Harpreet Saini committed professional misconduct in that

• He engaging in criminal harassment, which is an offence contrary to section 264(2)(a) of the Criminal Code, and in the conduct and acts which form the basis of that criminal finding of guilt;
• On or about September 19, 2018, he was found guilty of one count of criminal harassment, which is an offence contrary to section 264(2)(a) of the Criminal Code;
• He failed to report to the Registrar within 30 days the details of charges against him under the Criminal Code, as set out in an information sworn on or about August 22, 2017, as required by College By-Law No. 4, Article 12.1;
• He failed to report to the Registrar as soon as reasonably practicable and/or within 30 days the details of a finding against him under the Criminal Code, made on or about September 19, 2018, as required by section 85.6.1 of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991, and/or College By-Law No. 4, Article 12.1 and/or College By-Law No. 5, Article 13.1;
• He provided a false statement to the College in response to the question regarding a finding of guilt for an offence on the annual registration renewal questionnaire, on or about March 8, 2019.

In particular, it is alleged that he

• Was found guilty of an offence that is relevant to his suitability to practice;
• Contravened a term, condition or limitation imposed on his certificate of registration pursuant to section 5, paragraph (1)i and/or paragraph 5(ii) of Ontario Regulation 202/94;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement;
• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, he contravened section 85.6.1 of the Health Professions Procedural Code, being Schedule 2 to the Regulated Health Professions Act, 1991;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Saleh committed professional misconduct in that

• On or about September 14, 2017, he committed Sexual Assault, contrary to section 271 of the Criminal Code of Canada, for which he was found criminally guilty on March 6, 2019.

In particular, it is alleged that he

• Has been found guilty of an offence that is relevant to his suitability to practice;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hani Salib, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Queentario Pharmacy in Mississauga, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that

• Between about June 1, 2014 and November 1, 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of certain identified drugs and/or products that were not dispensed;
• Between about June 1, 2014 and November 1, 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified drugs and/or products that were not dispensed;
• Between about June 1, 2014 and November 1, 2016, he introduced into active inventory (or permitted, consented to or approved, expressly or impliedly, the introduction into active inventory of) certain identified drugs and/or products that were acquired from unauthorized and/or improper sources;
• Between about July 28, 2015 and November 4, 2016, he failed to discover and/or report a loss or theft of narcotics with respect to Oxycodone CR 40mg;
• Between about July 28, 2015 and November 4, 2016, he failed to perform and/or maintain accurate inventory counts and/or reconciliations of narcotics; and/or
• He dispensed a prescription for Oxycodone CR 80mg in doses and/or quantities that were clinically questionable, without taking and/or documenting appropriate and/or sufficient steps to assess the propriety of the prescription, on or about the following dates:
  • January 10, 2014
  • April 15, 2014
  • July 14, 2014
  • October 15, 2014
  • January 5, 2015
  • April 16, 2015
  • July 10, 2015

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession
• Falsified a record relating to his practice
• Submitted an account or charge for services that he knew was false or misleading
• Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
  • s. 42 of the Narcotic Control Regulations, CRC c 1041, made under the Controlled Drugs and Substances Act, SC 1996, c 19
• Returned to stock or again sold or dispensed a drug previously sold or dispensed and delivered
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Kaushil Shah, as staff pharmacist and/or Designated Manager at Pharma Centre Pharmacy in Toronto, Ontario, committed professional misconduct in that he:

• Sold by retail and/or dispensed prescription drugs to patients in the U.S. without a lawful and/or otherwise valid prescription;
• Contravened the OCP Policy on Prescriptions-Out of Country, dated January-February 2003; and/or
• Falsified records to indicate prescription drugs were being sold by retail and/or dispensed to patients in the U.S. pursuant to a lawful and/or otherwise valid prescription when no such authorization had been provided.

In particular, it is alleged that he:

• Failed to maintain a standard of practice of the profession;
• Falsified a record relating to his practice;
• Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 158 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
• Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections C.01.041 and/or C.01.042 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Sharma, as staff pharmacist at Torbram Pharmacy (“Pharmacy”) in Brampton, Ontario, and/or as director and shareholder of the corporate owner of the Pharmacy, committed professional misconduct with respect to certain identified false or unsubstantiated claims submitted by the Pharmacy to the Ontario Drug Benefit Program totaling approximately $190,000, in or about July 2015-June 2017.

In particular, it is alleged that she

• Failed to maintain a standard of practice of the profession

• Falsified a record relating to her practice (for conduct up to and including May 4, 2017), and/or
• Falsified a record relating to her practice or a person”™s health record (for conduct on or after May 5, 2017)

• Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement (for conduct up to and including May 4, 2017), and/or
• Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement (for conduct on or after May 5, 2017)

• Submitted an account or charge for services that she knew was false or misleading (for conduct up to and including May 4, 2017) and/or
• Submitted an account or charge for services or products that she knew or ought to have known was false or misleading (for conduct on or after May 5, 2017)

• Charged a fee that was excessive in relation to the service provided (for conduct up to and including May 4, 2017), and/or
• Charged a fee or amount that was excessive in relation to the service or product provided (for conduct on or after May 5, 2017)

• Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or section 27 of O.Reg. 201/96, as amended (for conduct up to and including May 4, 2017), and/or
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability Act and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or section 27 of O.Reg. 201/96, as amended (for conduct on or after May 5, 2017)

• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ashit Shihora committed professional misconduct in that during the period March 8, 2018 to July 3, 2019, at the VIP Pharmacy in Welland, Ontario, while his certificate of registration was suspended pursuant to an interim order of the Inquiries, Complaints and Reports Committee, he:

• Used the title “pharmacist” and/or held himself out as a person who is qualified to practice in Ontario as a pharmacist;
• Operated a pharmacy while it was not under the supervision of a pharmacist who was physically present;
• Was employed or worked in the pharmacy or otherwise engaged in the practice of pharmacy;
• Compounded, dispensed and/or sold a drug;
• Directed pharmacists and/or staff to bill the Ontario Drug Benefit Program for pharmaceutical opinions when he knew or ought to have known that they were not eligible for a professional services fee; and/or
• Managed and/or directed pharmacists and/or staff.

In particular, it is alleged that he:

• Contravened the Pharmacy Act, the Drug and Pharmacies Regulation Act R.S.O. 1990, c.H. 4, as amended, the Regulated Health Professions Act, 1991 S.O. 1991, c. 18, as amended, or the regulations under those Acts, and in particular,
  • ss. 10.(1) and/or ss. 10.(2) of the Pharmacy Act;
  • s. 143 and/or s.149 of the Drug and Pharmacies Regulation Act,
  • s. 27 of the Regulated Health Professions Act, 1991, with respect; and/or
  • s. 146 of the Drug and Pharmacies Regulation Act;
• Failed to comply with an interim order;
• Practiced the profession while his certificate of registration was suspended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Syed, as dispensing pharmacist and/or Designated Manager at MobilRx in Lynden, Ontario (“the Pharmacy”), and/or as director and shareholder of the corporation that owns the Pharmacy, committed professional misconduct, in or about January-February 2018, in that he:

• Dispensed less than the full quantity of the drug prescribed for the patient, [Patient 1], without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so, as required;
• Charged excessive dispensing fees for dispensing the drug prescribed for the patient, [Patient 1], on a daily basis rather than the full quantity prescribed, without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so; and/or
• Entered into an arrangement with [Person A], the manager of [Facility], requiring residents, including the patient, [Patient 1], to accept prescription services from the Pharmacy and/or for all prescriptions to be filled on a daily basis.

In particular, it is alleged that he:

• Failed to maintain the standard of practice of the profession;
• Failed to provide an appropriate level of supervision to a person whom he was professionally obligated to supervise;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Entered into an agreement that restricted a person’s choice of a pharmacist without the consent of the person;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
  • sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
  • sections 18 and/or 27 of Ontario Regulation 201/96, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Syed, as dispensing pharmacist and/or Designated Manager at MobilRx in Lynden, Ontario (“the Pharmacy”), and/or as director and shareholder of the corporation that owns the Pharmacy, committed professional misconduct, in or about February-May 2018, in that he

• Dispensed less than the full quantities of drugs prescribed for the patient, [Patient], without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so, as required;
• Charged excessive dispensing fees for dispensing the drugs prescribed for the patient, [Patient], on a daily basis rather than the full quantities prescribed, without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so; and/or
• Entered into an arrangement with [Person A], the manager of [Facility], requiring residents, including the patient, [Patient], to accept prescription services from the Pharmacy and/or for all prescriptions to be filled on a daily basis.

In particular, it is alleged that he

• Failed to maintain the standard of practice of the profession;
• Failed to provide an appropriate level of supervision to a person whom he was professionally obligated to supervise;
• Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
• Charged a fee or amount that was excessive in relation to the service or product provided;
• Entered into an agreement that restricted a person’s choice of a pharmacist without the consent of the person;
• Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
  • sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
  • sections 18 and/or 27 of Ontario Regulation 201/96, as amended;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
• Engaged in conduct that is unbecoming a member.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Thi Vuong, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Pacific Pharmacy Mississauga (the “Pharmacy”) in Mississauga, Ontario, committed professional misconduct in that she:

• Dispensed and/or billed for drugs and/or products without a prescription authorized by a prescriber for one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
• Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
• Falsified a record relating to her practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017;
• Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017; and/or
• Submitted an account or charge for services that she knew or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products from in or about January 2017 to in or about December 2017.

In particular, it is alleged that she:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting her patients and/or practice;
• Falsified a record relating to her practice and/or a person’s health record;
• Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement;
• Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading;
• Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act and section 20 of Ontario Regulation 264/16;
• Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
  • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act and section 20 of Ontario Regulation 264/16;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Brian White committed professional misconduct in that

• On or about October 21, 2017, or sometime after, he signed his name to hardcopy prescriptions, which he had not dispensed, dated October 20, 2017, which had actually been dispensed by a member whose certificate of registration he knew was suspended.

In particular, it is alleged that he

• Failed to maintain a standard of practice of the profession;
• Falsified a record related to his practice or a person’s health record;
• Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false a misleading or statement;
• Permitted, counselled or assisted, whether expressly or by implication, any member to contravene, or to practise in a manner that is inconsistent with a term, condition or limitation on that member’s certificate of registration;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Zandi, while engaged in the practice of pharmacy in Toronto, Ontario, on or about October 20, 2018, committed professional misconduct in that he

• Engaged in sexual touching of [Name] without her consent

In particular, it is alleged that he

• Contravened a federal law that is relevant to his suitability to practise: namely, s. 271 of the Criminal Code;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional;
• Engaged in conduct unbecoming a pharmacist.